Clinical trial
Hypofractionated Stereotactic Radiotherapy Versus Hippocampus-sparing Whole-brain Radiotherapy in Treating Cancer Patients With Brain Oligometastases: A Phase II Parallel Non-randomized and Prospective Observational Study
NCT05807165 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypofractionated Stereotactic Radiotherapy Versus Hippocampus-sparing Whole-brain Radiotherapy in Treating Cancer Patients With Brain Oligometastases: A Phase II Parallel Non-randomized and Prospective Observational Study
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 1, 2023
- Completion date
- July 31, 2026
- Enrollment
- 115 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain oligometastases